Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02534233 | Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium(ColdPlay2) | completed | N/A | 58 | Johns Hopkins UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06243666 | Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | active not recruiting | — | 2,188 | Xiamen UniversityOTHER | 1 | Jul 31, 2025 |
| clinicaltrials |
| NCT06866574 | A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males | active not recruiting | Phase 3 | 9,300 | Xiamen UniversityOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06967740 | Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs | recruiting | — | 200 | Nikola JanovskaOTHER_GOV | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07095478 | Safety and Efficacy of Oral Artesunate for Pre-cervical Cancer(NeoART-CIN) | not yet recruiting | Phase 2 | 28 | Metanoic Health Ltd.INDUSTRY | 1 | Jul 31, 2025 | clinicaltrials |
| NCT04788849 | Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples(Ext-VALHUDES) | completed | — | 300 | University of Milano BicoccaOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT05104099 | Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia(PhotodiVIN) | completed | Phase 2 | 17 | Institut de Cancérologie de LorraineOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | completed | Phase 3 | 91 | AIDS Malignancy ConsortiumNETWORK | 2 | Jul 23, 2025 | clinicaltrials |
| NCT02140021 | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer | terminated | N/A | 409 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06054841 | Reshaping Postpartum Follow-up | completed | N/A | 157 | Medstar Health Research InstituteOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07028242 | Ultrasound and Histology in AEH and Early EEC Treated Conservatively(ULTRA-SAFE) | not yet recruiting | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT05996783 | Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial(ScreenUrSelf) | active not recruiting | N/A | 48,000 | Universiteit AntwerpenOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT06562595 | What is the Optimal Training Model for Cervical Awareness? | completed | N/A | 400 | Izmir City HospitalOTHER_GOV | 1 | May 20, 2025 | clinicaltrials |
| NCT05555862 | Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL(anal HSIL HIV-) | active not recruiting | Phase 2 | 17 | Frantz Viral Therapeutics, LLCINDUSTRY | 1 | May 18, 2025 | clinicaltrials |
| NCT03061435 | Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.(Vulvar-AIN) | recruiting | N/A | 110 | Dr. Danielle VicusOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT05647109 | Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | recruiting | — | 244 | Peking University People's HospitalOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT04278326 | Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments(ORGANOIDES) | terminated | N/A | 14 | Centre Hospitalier Régional d'OrléansOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT05266898 | Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV(AGO-Gard) | recruiting | Phase 4 | 250 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT03267680 | IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | terminated | Phase 2 | 10 | University of Southern CaliforniaOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT03196180 | Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia | completed | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06915779 | Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | completed | — | 241 | University of British ColumbiaOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT03084081 | An Innovative Treatment for Cervical Precancer (UH3)(UH3) | completed | N/A | 1,132 | The Cleveland ClinicOTHER | 3 | Apr 6, 2025 | clinicaltrials |
| NCT06452004 | Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)(AI-DSS) | unknown | N/A | 600 | University Medical Center GroningenOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06137950 | Interferon Alpha Therapy for Cervical CINI and HPV Infection | completed | Phase 1 | 60 | Mongolian National University of Medical SciencesOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05284877 | The Organ Transplant Recipient HPV and Skin Cancer Study | recruiting | — | 1,500 | Merete HaedersdalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04915495 | The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia | enrolling by invitation | N/A | 400 | Guided TherapeuticsINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06078514 | Sexual Function and Quality of Life After LEEP: a Prospective Multi-Center Study(SEQUEL) | recruiting | — | 1,000 | Tampere University HospitalOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05229679 | HPV-based Screening Among Women 23-29 Years of Age | recruiting | N/A | 180,000 | Karolinska InstitutetOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05640700 | Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia | recruiting | — | 90 | Hadassah Medical OrganizationOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06866392 | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol(CC-AZ) | not yet recruiting | — | 4,200 | Peking Union Medical College HospitalOTHER | 0 | Mar 10, 2025 | clinicaltrials |
| NCT04276935 | Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions | completed | — | 20 | AIDS Malignancy ConsortiumNETWORK | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06149598 | Coughing at Time of Cervical Biopsy | completed | N/A | 30 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06316882 | Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program(ROGCAS) | completed | — | 349 | Unidade Local De Saúde Do Norte AlentejanoOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06258564 | The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization | completed | — | 12,000 | Charles University, Czech RepublicOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06823817 | Quality Control of Colposcopy Application(QCCA) | completed | — | 10,000 | Peking Union Medical College HospitalOTHER | 0 | Feb 12, 2025 | clinicaltrials |
| NCT05717621 | Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN)(DelVIN) | completed | Phase 1 | 29 | ViMREX GmbHINDUSTRY | 1 | Feb 11, 2025 | clinicaltrials |
| NCT05078528 | Low-cost Imaging Technology for Global Prevention of Cervical Cancer | recruiting | N/A | 1,060 | Barretos Cancer HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT05496231 | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | completed | Phase 1 / Phase 2 | 1,080 | GlaxoSmithKlineINDUSTRY | 8 | Feb 3, 2025 | clinicaltrials |
| NCT05391243 | Large Loop Excision of the Transformation Zone During Follicular Vs. Luteal Phase of the Menstrual Cycle (LLETZ-MC)(LLETZ-MC) | not yet recruiting | N/A | 152 | Ruhr University of BochumOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT04772937 | Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia | recruiting | N/A | 206 | Ruhr University of BochumOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT02149030 | Effectiveness of Cervical Screening in HPV Vaccinated Women(HPV-004) | active not recruiting | N/A | 6,958 | Tampere UniversityOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT04755517 | Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400)(HPV400) | enrolling by invitation | N/A | 14,000 | Tampere University HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06745427 | A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia(PreFerEC/EIN) | not yet recruiting | — | 100 | Region StockholmOTHER_GOV | 0 | Dec 20, 2024 | clinicaltrials |
| NCT06741150 | NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06465914 | A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males | active not recruiting | Phase 3 | 9,000 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06713655 | Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation | not yet recruiting | — | 800 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT03792516 | Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)(ART-VIN) | completed | Phase 1 | 15 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 4, 2024 | clinicaltrials |
| NCT06700941 | Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment | completed | — | 8,000,000 | Universidad Nacional de ColombiaOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT06525870 | Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial(Trichlosil) | unknown | Phase 2 | 44 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Nov 14, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 1, 2025source: clinicaltrials